<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 193 cases autopsied between 1945 and 1980, <z:hpo ids='HP_0000001'>all</z:hpo> persons who had been intravascularly injected with Thorotrast in life, the authors found 131 malignant <z:mpath ids='MPATH_352'>hepatic tumors</z:mpath>, 20 liver <z:e sem="disease" ids="C1623038" disease_type="Disease or Syndrome" abbrv="">cirrhoses</z:e>, 6 myeloid <z:hpo ids='HP_0001909'>leukemias</z:hpo>, 4 erythroleukemias, 5 <z:hpo ids='HP_0001915'>aplastic anemias</z:hpo>, 4 lung <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, 1 <z:mpath ids='MPATH_365'>mesothelioma</z:mpath> and 1 <z:hpo ids='HP_0002669'>osteosarcoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The causes of <z:hpo ids='HP_0011420'>death</z:hpo> in the Thorotrast-administered autopsy group (193 cases) were compared with those of a non-Thorotrast-administered autopsy group (95,000 cases) of the same sex and age at <z:hpo ids='HP_0011420'>death</z:hpo> as recorded in the Annals of Japanese Pathological Autopsy cases from 1958 to 1978 </plain></SENT>
<SENT sid="2" pm="."><plain>This comparison revealed that the frequencies of malignant <z:mpath ids='MPATH_352'>hepatic tumors</z:mpath>, liver <z:hpo ids='HP_0001394'>cirrhosis</z:hpo>, <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e>, and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> were significantly higher in the Thorotrast-administered group than in the non-Thorotrast-administered group </plain></SENT>
</text></document>